Sage gets U.S. approval for first postpartum depression therapy

The U.S. Food and Drug Administration on Tuesday approved Sage Therapeutics Inc's drug for postpartum depression, marking the first approval of a treatment specifically developed for the condition that affects a new mother's ability to care for herself or her baby.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news